- $195.32m
- $131.78m
- $62.45m
- 79
- 39
- 54
- 59
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 21.2 | 24.6 | 43.3 | 61.3 | 62.5 |
Cost of Revenue | |||||
Gross Profit | 12.2 | 15.4 | 24.1 | 35.6 | 39 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 21 | 28.3 | 45.4 | 60.9 | 74.7 |
Operating Profit | 0.18 | -3.69 | -2.14 | 0.361 | -12.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.226 | -4.04 | -2.21 | 0.378 | -11.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.226 | -3.14 | -2.21 | 0.378 | -11.4 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.226 | -3.14 | -2.21 | 0.378 | -11.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.226 | -3.14 | -2.21 | 0.378 | -11.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.019 | -0.235 | -0.149 | 0.021 | -0.643 |